Concepedia

The diagnostic and prognostic usage of circulating tumor DNA in operable hepatocellular carcinoma.

Yan An, Yanfang Guan, Yaping Xu, Yingxin Han, Chi Wu, Chaohui Bao, Boping Zhou, Haiyan Wang, Mingxia Zhang, Weilong Liu,

PubMed · 2019 · 46 citations · 28 references

Concepts

Abstract

< 0.0001) was an independent risk factors for recurrence. In conclusion, ctDNA profiling is potentially valuable in differential diagnosis and prognostic evaluation of HCC.

References

28

Global cancer statistics, 2012

Lindsey A. Torre, Freddie Bray, Rebecca L. Siegel et al. · CA A Cancer Journal for Clinicians · 2015 · 27.4K citations · Full text

, , +16

Cancer statistics in China, 2015

Wanqing Chen, Rongshou Zheng, Peter D. Baade et al. · CA A Cancer Journal for Clinicians · 2016 · 18K citations · Full text

, , +17

Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies

Chetan Bettegowda, Mark Sausen, Rebecca Leary et al. · Science Translational Medicine · 2014 · 5.1K citations · Full text

, , +17

Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA Sequence

Giulio Genovese, Anna K. Kähler, Robert E. Handsaker et al. · New England Journal of Medicine · 2014 · 3.5K citations · Full text

, , +16

Circulating mutant DNA to assess tumor dynamics

Frank Diehl, Kerstin Schmidt, Michael A. Choti et al. · Nature Medicine · 2008 · 2.7K citations · Full text

, , +14